Biologics R&D

The research and development (R&D) facility conducts discovery and early development of therapeutic protein drugs, particularly therapeutic antibodies.

The R&D laboratories located in Sydney, employ state of the art technologies to identify, produce and characterize therapeutic protein candidates.  When these potential drugs have been demonstrated to have suitable drug-like properties and genuine scope to provide patient benefit they are transferred to other parts of Teva’s R&D organization for further development and progression to the clinic.  The key skillsets of the Biologics R&D scientists are:

·         Protein and antibody engineering

·         Cell biology and pharmacology

·         Therapeutic protein production, purification and characterization.

Utilizing these technologies and expertise, the group has a track record of advancing several protein therapeutics into clinical trials.